[
    {
        "Header Number": "N/A",
        "Title": "Statistical Analysis Plan 20060359",
        "Content": "Product:  Denosumab Statistical Analysis Plan: 20060359Version 3.0 Addendum Dated: 26 March 2018Page 2",
        "Sub-sections": [
            {
                "Header Number": "N/A",
                "Title": "Table of Contents",
                "Content": "Table of Abbreviations.....................................................................................................31.Introduction.............................................................................................................42.Study Endpoints .....................................................................................................42.1Efficacy Endpoint ........................................................................................42.2Safety Endpoints.........................................................................................53.Statistical Methods of Analysis................................................................................53.1Subject Accountability .................................................................................53.2Efficacy Analyses........................................................................................53.3Safety Analyses ..........................................................................................6Product:  Denosumab Statistical Analysis Plan: 20060359Version 3.0 Addendum Dated: 26 March 2018Page 3",
                "Sub-sections": []
            },
            {
                "Header Number": "N/A",
                "Title": "Table of Abbreviations",
                "Content": "AbbreviationDefinitionAEadverse eventAFFatypical femoral fractureCRFcase report formCTCAEcommon terminology criteria for adverse EventsEOIevent of interestEOTPend of treatment phaseIPinvestigational productLTFUlong-term follow-upMedDRAmedical dictionary for regulatory activitiesONJosteonecrosis of the jawPTpreferred termSAEserious adverse eventSAPstatistical analysis plan",
                "Sub-sections": []
            },
            {
                "Header Number": "1.",
                "Title": "Introduction",
                "Content": "",
                "Sub-sections": []
            },
            {
                "Header Number": "2.",
                "Title": "Study Endpoints",
                "Content": "",
                "Sub-sections": [
                    {
                        "Header Number": "2.1",
                        "Title": "Efficacy Endpoint",
                        "Content": "",
                        "Sub-sections": []
                    },
                    {
                        "Header Number": "2.2",
                        "Title": "Safety Endpoints",
                        "Content": "",
                        "Sub-sections": []
                    }
                ]
            },
            {
                "Header Number": "3.",
                "Title": "Statistical Methods of Analysis",
                "Content": "",
                "Sub-sections": [
                    {
                        "Header Number": "3.1",
                        "Title": "Subject Accountability",
                        "Content": "",
                        "Sub-sections": []
                    },
                    {
                        "Header Number": "3.2",
                        "Title": "Efficacy Analyses",
                        "Content": "",
                        "Sub-sections": []
                    },
                    {
                        "Header Number": "3.3",
                        "Title": "Safety Analyses",
                        "Content": "",
                        "Sub-sections": []
                    }
                ]
            }
        ]
    }
]